People in the News: Michael Little, George Yancopoulos, and Tina Nova | GenomeWeb

Michael Little

Natera has appointed Michael Little as senior vice president of research and development. Prior to Natera, Little was the global head of diagnostics development at Novartis. Before that, he served as vice president of research and development, vice president of medical affairs, vice president of regulatory and scientific affairs, and the vice president of program management at Novartis Diagnostics.

George Yancopoulos

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.